|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.37 AUD | +3.40% |
|
+5.38% | -5.19% |
| Apr. 01 | Cogstate Amends License Agreement with Eisai for Alzheimer’s Treatment | MT |
| Feb. 22 | Cogstate's Fiscal H1 Attributable Profit Jumps, Revenue Rises 3%; Shares Decline 8% | MT |
Cogstate Limited (ASX:CGS) announces a share repurchase program. Under the program, the company will repurchase up to 5,000,000 shares, representing 2.92% of its issued share capital. The purpose of the program is to improve returns for shareholders.
The program is valid till March 13, 2025. As of February 22, 2024, the company had 171,369,328 shares issued and outstanding.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.19% | 153M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
COGSTATE LIMITED 
